HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yulia Dorofeeva Selected Research

Allergens

1/2021Past, present, and future of allergen immunotherapy vaccines.
10/2019Expression and characterization of recombinant Par j 1 and Par j 2 resembling the allergenic epitopes of Parietaria judaica pollen.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yulia Dorofeeva Research Topics

Disease

4COVID-19
11/2022 - 01/2021
3Hypersensitivity (Allergy)
01/2023 - 10/2019
3Infections
11/2022 - 01/2021
1Asthma (Bronchial Asthma)
10/2019
1Seasonal Allergic Rhinitis (Hay Fever)
10/2019

Drug/Important Bio-Agent (IBA)

3VaccinesIBA
11/2022 - 10/2019
2Peptides (Polypeptides)IBA
11/2022 - 01/2022
2Proteins (Proteins, Gene)FDA Link
01/2022 - 01/2021
2AntibodiesIBA
01/2022 - 01/2021
2AllergensIBA
01/2021 - 10/2019
2Immunoglobulin E (IgE)IBA
01/2021 - 10/2019
1Surface Antigens (Surface Antigen)IBA
01/2023
1CytokinesIBA
11/2022
1Enterotoxins (Enterotoxin)IBA
11/2022
1Interleukin-2 (IL2)IBA
11/2022
1Interleukin-13IBA
11/2022
1Tetanus Toxoid (Vaccine, Tetanus)FDA Link
11/2022
1PhytohemagglutininsIBA
11/2022
1AntigensIBA
11/2022
1Protein SIBA
01/2022
1HLA-DR Antigens (HLA-DR)IBA
01/2021
1Virus ReceptorsIBA
01/2021
1EpitopesIBA
10/2019

Therapy/Procedure

2Immunotherapy
01/2021 - 10/2019